These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
379 related items for PubMed ID: 29164926
1. Serum uric acid level predicts adverse outcomes after myocardial revascularization or cardiac valve surgery. Lazzeroni D, Bini M, Camaiora U, Castiglioni P, Moderato L, Bosi D, Geroldi S, Ugolotti PT, Brambilla L, Brambilla V, Coruzzi P. Eur J Prev Cardiol; 2018 Jan; 25(2):119-126. PubMed ID: 29164926 [Abstract] [Full Text] [Related]
2. Prognostic value of frontal QRS-T angle in patients undergoing myocardial revascularization or cardiac valve surgery. Lazzeroni D, Bini M, Camaiora U, Castiglioni P, Moderato L, Ugolotti PT, Brambilla L, Brambilla V, Coruzzi P. J Electrocardiol; 2018 Jan; 51(6):967-972. PubMed ID: 30497757 [Abstract] [Full Text] [Related]
3. In-hospital day-by-day systolic blood pressure variability during rehabilitation: a marker of adverse outcome in secondary prevention after myocardial revascularization. Lazzeroni D, Camaiora U, Castiglioni P, Bini M, Garibaldi S, Geroldi S, Moderato L, Brambilla L, Brambilla V, Parati G, Coruzzi P. J Hypertens; 2020 Sep; 38(9):1729-1736. PubMed ID: 32516294 [Abstract] [Full Text] [Related]
4. Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery. van Diepen S, Mehta RH, Leimberger JD, Goodman SG, Fremes S, Jankowich R, Heringlake M, Anstrom KJ, Levy JH, Luber J, Nagpal AD, Duncan AE, Argenziano M, Toller W, Teoh K, Knight JD, Lopes RD, Cowper PA, Mark DB, Alexander JH. J Thorac Cardiovasc Surg; 2020 Jun; 159(6):2302-2309.e6. PubMed ID: 31358329 [Abstract] [Full Text] [Related]
5. Elevated postoperative serum uric acid is associated with major adverse events following coronary artery bypass grafting. Shi Y, Zhang X, Du J, Chen S, Zhang H, Yang L, Zheng Z. J Card Surg; 2020 Oct; 35(10):2559-2566. PubMed ID: 33043654 [Abstract] [Full Text] [Related]
6. The burden of major adverse cardiac events in patients with coronary artery disease. Tsai IT, Wang CP, Lu YC, Hung WC, Wu CC, Lu LF, Chung FM, Hsu CC, Lee YJ, Yu TH. BMC Cardiovasc Disord; 2017 Jan 04; 17(1):1. PubMed ID: 28052754 [Abstract] [Full Text] [Related]
7. Impact of smoking status on outcomes after concomitant aortic valve replacement and coronary artery bypass graft surgery. Saxena A, Shan L, Dinh DT, Reid CM, Smith JA, Shardey GC, Newcomb AE. Thorac Cardiovasc Surg; 2014 Feb 04; 62(1):52-9. PubMed ID: 24163261 [Abstract] [Full Text] [Related]
8. Factors associated with postoperative atrial fibrillation and other adverse events after cardiac surgery. Akintoye E, Sellke F, Marchioli R, Tavazzi L, Mozaffarian D. J Thorac Cardiovasc Surg; 2018 Jan 04; 155(1):242-251.e10. PubMed ID: 28890081 [Abstract] [Full Text] [Related]
15. A propensity-score matched analysis on the impact of postoperative atrial fibrillation on the early and late outcomes after concomitant aortic valve replacement and coronary artery bypass graft surgery. Saxena A, Shi WY, Paramanathan A, Herle P, Dinh D, Smith JA, Reid CM, Shardey G, Newcomb AE. J Cardiovasc Med (Hagerstown); 2014 Mar 04; 15(3):199-206. PubMed ID: 24572338 [Abstract] [Full Text] [Related]
16. Referral to Cardiac Rehabilitation After Percutaneous Coronary Intervention, Coronary Artery Bypass Surgery, and Valve Surgery: Data From the Clinical Outcomes Assessment Program. Beatty AL, Bradley SM, Maynard C, McCabe JM. Circ Cardiovasc Qual Outcomes; 2017 Jun 04; 10(6):. PubMed ID: 28619725 [Abstract] [Full Text] [Related]
17. Impact of sex on uric acid levels and its relationship with the extent of coronary artery disease: A single-centre study. Barbieri L, Verdoia M, Schaffer A, Marino P, Suryapranata H, De Luca G, Novara Atherosclerosis Study Group (NAS). Atherosclerosis; 2015 Jul 04; 241(1):241-8. PubMed ID: 25818387 [Abstract] [Full Text] [Related]
18. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3--valve plus coronary artery bypass grafting surgery. Shahian DM, O'Brien SM, Filardo G, Ferraris VA, Haan CK, Rich JB, Normand SL, DeLong ER, Shewan CM, Dokholyan RS, Peterson ED, Edwards FH, Anderson RP, Society of Thoracic Surgeons Quality Measurement Task Force. Ann Thorac Surg; 2009 Jul 04; 88(1 Suppl):S43-62. PubMed ID: 19559824 [Abstract] [Full Text] [Related]